Related Experiment Video
Updated: May 3, 2026

13:47
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
9.3K
Interleukin-20 receptor expression in the trabecular meshwork and its implication in glaucoma.
Kate E Keller1, Yong-Feng Yang, Ying Ying Sun
1Casey Eye Institute, Oregon Health & Sciences University , Portland, Oregon.
Summary
A mutation in interleukin-20 receptors (IL-20R2) impacts cellular function, decreasing signal transducer and activator of transcription 3 (STAT3) phosphorylation and matrix metalloproteinase (MMP) activity, potentially affecting glaucoma outflow resistance.
Area of Science:
- Ophthalmology
- Cell Biology
- Genetics
Background:
- Interleukin-20 receptors (IL-20R) play roles in inflammatory and cellular processes.
- Trabecular meshwork (TM) cells are crucial for regulating intraocular pressure (IOP) in the eye.
- Genetic mutations in IL-20R2 have been linked to primary open-angle glaucoma (POAG).
Purpose of the Study:
- To investigate the expression of IL-20 receptors (IL-20R1 and IL-20R2) in human trabecular meshwork (HTM) cells.
- To determine the functional consequences of a specific T104M mutation in IL-20R2 on cellular signaling and activity.
Main Methods:
- Immunohistochemistry and western immunoblotting were used to detect IL-20R expression in HTM cells.
- Primary open-angle glaucoma (POAG) dermal fibroblasts (pHDF) with the IL-20R2 T104M mutation were compared to normal human dermal fibroblasts (HDF).
- Signal transducer and activator of transcription 3 (STAT3) phosphorylation and matrix metalloproteinase (MMP) activity were measured in response to IL-20 stimulation.
Main Results:
- The T104M mutation in IL-20R2 was identified in a POAG family.
- pHDFs with the mutation showed altered STAT3 phosphorylation and significantly decreased MMP activity compared to controls.
- IL-20R1 and IL-20R2 were expressed in HTM cells and appeared upregulated by cytokine treatment.
Conclusions:
- The T104M mutation in IL-20R2 significantly impairs receptor function, leading to reduced STAT3 phosphorylation and MMP activity.
- Decreased MMP activity in glaucoma patients may compromise their ability to modulate outflow resistance in response to elevated IOP.
- IL-20R signaling is implicated in the cellular mechanisms underlying glaucoma pathogenesis.
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

